Tokyo, Japan

Shogo Hirota

This inventor holds 1 USPTO granted patent. Top assignees: Brightpath Biotherapeutics Co., Ltd., Kyoto Prefectural Public University Corporation, Shinshu University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shogo Hirota. Retrieved from https://idiyas.com/inventor/shogo-hirota-xr19b1p0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shogo Hirota: Innovator in Immune Cell Production

Introduction

Shogo Hirota is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of immunology, particularly in the production of immune cells. His innovative work has led to advancements that may impact therapeutic strategies in various medical applications.

Latest Patents

Hirota holds a patent titled "Method for Producing Cell Population Containing CAR-Expressing Immune Cells." This patent highlights his expertise in developing methods that enhance the efficacy of immune cells for therapeutic use. He has 1 patent to his name, showcasing his commitment to innovation in this critical area of research.

Career Highlights

Throughout his career, Shogo Hirota has worked with esteemed institutions such as Shinshu University and Kyoto Prefectural Public University Corporation. His roles in these organizations have allowed him to collaborate with other experts and contribute to groundbreaking research in immunology.

Collaborations

One of his notable collaborators is Shigeki Yagyu. Their partnership has likely fostered a productive exchange of ideas and expertise, further enhancing the impact of their research.

Conclusion

Shogo Hirota's contributions to the field of immunology through his innovative patent and collaborations with leading institutions underscore his role as a significant inventor. His work continues to pave the way for advancements in immune cell therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…